The United States Centers for Disease Control and Prevention (CDC) has changed a major public health policy and ended its long-standing recommendation that every newborn baby receive the hepatitis B vaccine at birth. This decision marks a significant shift in how doctors will advise parents about the vaccine going forward.
Under the new policy, the CDC will only strongly suggest the birth dose of the hepatitis B vaccine for infants whose mothers test positive for hepatitis B or whose infection status is unknown. For babies whose mothers test negative for the virus, the choice of when or whether to give the vaccine is now left to parents and their doctors. If parents do not want the vaccine right after birth, the CDC recommends waiting until the child is at least two months old before giving the first dose.
This change comes after the CDC’s vaccine advisory panel made the recommendation to shift away from universal newborn vaccination. The panel argued that better maternal screening and lower risk of early hepatitis B infection mean parents should have a greater role in deciding the timing of vaccination. The CDC accepted this advice and made it official policy this week.
For more than 30 years, health officials in the US recommended that all newborns be vaccinated against hepatitis B within the first 24 hours of life. That policy was put in place to sharply reduce the risk of babies catching the virus from infected mothers or during early childhood. Since the original recommendation began in the early 1990s, hepatitis B infections in the United States have dropped dramatically.
However, the new guidance has drawn strong criticism from many public health experts, doctors, and medical organizations. Critics say that removing the universal birth-dose recommendation could lead to more children getting infected with a virus that can cause serious liver disease or cancer later in life. They argue that the previous policy helped protect babies when maternal testing could miss infections or when parents did not follow up with later medical appointments.
The CDC’s recommendations play a central role in shaping medical practice, insurance coverage, and health provider advice across the country. With this policy change, families and clinicians will now need to make more decisions together about how and when to protect infants from hepatitis B.
